PRME
Price
$5.45
Change
-$0.35 (-6.03%)
Updated
Oct 17 closing price
Capitalization
971.59M
12 days until earnings call
Intraday Buy/Sell Signals
SEER
Price
$2.16
Change
-$0.05 (-2.26%)
Updated
Oct 17 closing price
Capitalization
121.69M
17 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

PRME vs SEER

Header iconPRME vs SEER Comparison
Open Charts PRME vs SEERBanner chart's image
Prime Medicine
Price$5.45
Change-$0.35 (-6.03%)
Volume$3.57M
Capitalization971.59M
Seer
Price$2.16
Change-$0.05 (-2.26%)
Volume$67.05K
Capitalization121.69M
PRME vs SEER Comparison Chart in %
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. SEER commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and SEER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 20, 2025
Stock price -- (PRME: $5.45 vs. SEER: $2.16)
Brand notoriety: PRME and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 100% vs. SEER: 53%
Market capitalization -- PRME: $971.59M vs. SEER: $121.69M
PRME [@Biotechnology] is valued at $971.59M. SEER’s [@Biotechnology] market capitalization is $121.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, SEER is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 3 TA indicator(s) are bullish while SEER’s TA Score has 6 bullish TA indicator(s).

  • PRME’s TA Score: 3 bullish, 6 bearish.
  • SEER’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SEER is a better buy in the short-term than PRME.

Price Growth

PRME (@Biotechnology) experienced а -4.05% price change this week, while SEER (@Biotechnology) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

PRME is expected to report earnings on Oct 31, 2025.

SEER is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($972M) has a higher market cap than SEER($122M). PRME YTD gains are higher at: 86.644 vs. SEER (-6.494). SEER has higher annual earnings (EBITDA): -82.75M vs. PRME (-197.38M). SEER has more cash in the bank: 210M vs. PRME (102M). SEER has less debt than PRME: SEER (24.8M) vs PRME (120M). SEER has higher revenues than PRME: SEER (16M) vs PRME (4.96M).
PRMESEERPRME / SEER
Capitalization972M122M797%
EBITDA-197.38M-82.75M239%
Gain YTD86.644-6.494-1,334%
P/E RatioN/AN/A-
Revenue4.96M16M31%
Total Cash102M210M49%
Total Debt120M24.8M484%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMESEER
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SASOF6.20N/A
N/A
Sasol Ltd.
CYDX0.44N/A
N/A
CYduct Diagnostics Inc.
CCTSF11.79N/A
N/A
Cactus Acquisition Corp. 1 Limited
HLMAF46.72-0.74
-1.57%
Halma PLC
MGMNF2.08-0.15
-6.72%
Magna Mining Inc.

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-6.03%
CRSP - PRME
59%
Loosely correlated
+1.05%
BEAM - PRME
56%
Loosely correlated
+0.74%
RXRX - PRME
55%
Loosely correlated
-7.86%
EDIT - PRME
48%
Loosely correlated
-4.80%
NTLA - PRME
48%
Loosely correlated
-0.64%
More